Evidence map›Paper›PMID 17329356›Full record

ArticleRNA (New York, N.Y.)2007

An mRNA sequence derived from the yeast EST3 gene stimulates programmed +1 translational frameshifting.

Dwayne Taliaferro, Philip J Farabaugh

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. An Expanded CAG Repeat in Huntingtin Causes +1 Frameshifting.The Journal of biological chemistry · 2016
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dwayne TaliaferroDepartment of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, USA.
Philip J Farabaugh
University of Maryland, Baltimore County · US

Funding

The genetics of ribosomal reading frame maintenanceR01GM029480 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI FARABAUGH, PHILIP JAMES · 1985 to 2010
$2.7M
Molecular Basis for Selection in the A siteF31GM073575 · NIGMS · UNIVERSITY OF MARYLAND BALT CO CAMPUS · PI TALIAFERRO, DWAYNE · 2004 to 2005
$48k
NIGMS NIH HHS F31 GM073575NIGMS NIH HHS R01 GM029480
6 · The paper itself

Abstract

Programmed translational frameshift sites are sequences in mRNAs that promote frequent stochastic changes in translational reading frame allowing expression of alternative forms of protein products. The EST3 gene of Saccharomyces cerevisiae, encoding a subunit of telomerase, uses a programmed +1 frameshift site in its expression. We show that the site is complex, consisting of a heptameric sequence at which the frameshift occurs and a downstream 27-nucleotide stimulator sequence that increases frameshifting eightfold. The stimulator appears to be modular, composed of at least three separable domains. It increases frameshifting only when ribosomes pause at the frameshift site because of a limiting supply of a cognate aminoacyl-tRNA and not when pausing occurs at a nonsense codon. These data suggest that the EST3 stimulator may modulate access by aminoacyl-tRNAs to the ribosomal A site by interacting with several targets in a ribosome paused during elongation.

Indexed as

Frameshifting, RibosomalGenes, FungalBase Sequencebeta-GalactosidaseFungal ProteinsMolecular Sequence DataMutation, MissenseNucleic Acid ConformationPlasmidsRNA, MessengerSaccharomyces cerevisiaeSequence Homology, Nucleic Acidbeta-GalactosidaseFungal ProteinsRNA, Messenger

Identifiers

PMID17329356
PMCPMC1831869
OpenAlexW2124185752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.